James Shin
Stock Analyst at Deutsche Bank
(2.67)
# 1,943
Out of 5,141 analysts
24
Total ratings
54.55%
Success rate
21.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $1,009.52 | +27.29% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $122.26 | -9.21% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.06 | -0.60% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $151.40 | -20.74% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $374.75 | -18.61% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $101.32 | -40.78% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $60.66 | -25.82% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $18.12 | +231.13% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $224.81 | -33.28% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $779.67 | +2.61% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.67 | +498.80% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $18.42 | +551.47% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $1,009.52
Upside: +27.29%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $122.26
Upside: -9.21%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.06
Upside: -0.60%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $151.40
Upside: -20.74%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $374.75
Upside: -18.61%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $101.32
Upside: -40.78%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $60.66
Upside: -25.82%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $18.12
Upside: +231.13%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $224.81
Upside: -33.28%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $779.67
Upside: +2.61%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.67
Upside: +498.80%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $18.42
Upside: +551.47%